Search Results | Cancer Research | American Association for Cancer Research

1-20 of 57

2 3

Sort by

Sort Order Select

Journal Articles

Abstract 1724: Pancancer evaluation of tumor infiltrating lymphocytes (TILs) and PD-L1 in SHIVA-01 trial patients with different biopsy sites and histological types

Zakhia El Beaino, Célia Dupain, Grégoire Marret, Xavier Paoletti, Laëtitia Fuhrmann, Charlotte Martinat, Ivan Bièche, Christophe Le Tourneau, Maud Kamal, Anne Vincent-Salomon

Cancer Res (2022) 82 (12_Supplement): 1724.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1724

Published: 15 June 2022

View article

Journal Articles

Abstract PD11-04: A multi-feature AI-based solution for cancer diagnosis in breast biopsies: A prospective blinded multi-site clinical study

Anne Vincent-Salomon, Guillaume Bataillon, Alona Nudelman, Judith Sandbank, Anat Albrecht Shach, Lucie Thibault, Lilach Bien, Rachel Mikulinsky, Ira Krasnitsky, Ronen Heled, Chaim Linhart, Manuela Vecsler, Daphna Laifenfeld

Cancer Res (2022) 82 (4_Supplement): PD11-04.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD11-04

Published: 15 February 2022

View article

Journal Articles

Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC)

Cancer Res (2022) 82 (4_Supplement): P1-02-09.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-02-09

Published: 15 February 2022

View article

Journal Articles

Abstract P1-07-01: Real time detection of ESR1 mutation in blood by droplet digital PCR in the PADA-1 trial: Feasibility and cross-validation with NGS

Cancer Res (2022) 82 (4_Supplement): P1-07-01.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-07-01

Published: 15 February 2022

View article

Journal Articles

Abstract PS12-03: Letrozole and palbociclib versus 3^rd generation chemotherapy as neoadjuvant treatment in luminal breast cancer: Survival results of the UNICANCER-NeoPAL study

Cancer Res (2021) 81 (4_Supplement): PS12-03.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS12-03

Published: 15 February 2021

View article

Journal Articles

Abstract P2-14-10: Prosigna® test in clinical routine: Impact on adjuvant chemotherapy decision and medico-economic considerations in France

Delphine Hequet, Guillaume Harrissart, Celine Callens, David Gentien, Ivan Bieche, Paul Cottu, Jean-Marc Guinebretiere, Anne Vincent-Salomon, Florence Lerebours, Roman Rouzier

Cancer Res (2020) 80 (4_Supplement): P2-14-10.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-14-10

Published: 15 February 2020

View article

Journal Articles

Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP

Youlia M. Kirova, Delphine Loirat, Frederique Berger, Manuel Rodrigues, Louis Bazire, Anne Chilles, Jean Yves Pierga, Francesco Ricci, Marie Paule Sablin, Anne Vincent Salomon, Fatima Laki, Claire Bertrand, Cyrine Ezzili, Laurence Raizoville, Veronique Mosseri, Souhir Neffati, Monia Ezzalfani, Alain Fourquet

Cancer Res (2020) 80 (4_Supplement): OT2-03-01.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT2-03-01

Published: 15 February 2020

View article

Journal Articles

Abstract P2-08-21: Outcomes results of Prosigna® test in early breast cancer patients: Experience of Institut Curie, France

Delphine Hequet, Louise Maumy, Celine Callens, David Gentien, Ivan Bieche, Paul Cottu, Jean-Marc Guinebretiere, Anne Vincent-Salomon, Florence Lerebours, Roman Rouzier

Cancer Res (2020) 80 (4_Supplement): P2-08-21.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-08-21

Published: 15 February 2020

View article

Journal Articles

Abstract P5-02-04: Upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast to reduce inter-observer variability: The DCISion study

Cancer Res (2020) 80 (4_Supplement): P5-02-04.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-02-04

Published: 15 February 2020

View article

Journal Articles

Abstract 3867: Activating ESR1 mutations detection by single ddPCR assay

Francois-Clement Bidard, Emmanuelle Jeannot, Luc Cabel, Nicolas Epaillard, Radouane El Ayachy, Aurelien Noret, Anne Vincent-Salomon, Jean-Yves Pierga, Ivan Bieche, Charlotte Proudhon, Marc-Henri Stern

Cancer Res (2018) 78 (13_Supplement): 3867.

DOI: https://doi.org/10.1158/1538-7445.AM2018-3867

Published: 01 July 2018

View article

Journal Articles

Abstract 774: Anti-Müllerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy

Cancer Res (2018) 78 (13_Supplement): 774.

DOI: https://doi.org/10.1158/1538-7445.AM2018-774

Published: 01 July 2018

View article

Journal Articles

Abstract 2973: A comprehensive panel of patient-derived xenografts representing the molecular heterogeneity and diversity of triple-negative breast cancer

Florence Coussy, Virginie Bernard, Marion Lavigne, Anais Boulai, Sophie Chateau-Joubert, Ahmed Dahmani, Elodie Montaudon, Cécile Reyes, Rania El Botty, Gaëlle Pieron, Cécile Laurent, Samia Melaabi, Anne Vincent Salomon, Ivan Bièche, Elisabetta Marangoni

Cancer Res (2018) 78 (13_Supplement): 2973.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2973

Published: 01 July 2018

View article

Journal Articles

Abstract 1524: Mutations and gene copy number variations landscape of metastases of various cancer types from patients enrolled in the SHIVA trial

Maud Kamal, Nicolas Servant, Gaelle Pierron, Celine Callens, David Gentien, Alban Lermine, Georges Lucotte, Virginie Bernard, Anne Vincent-Salomon, Ivan Bièche, Christophe Le Tourneau

Cancer Res (2016) 76 (14_Supplement): 1524.

DOI: https://doi.org/10.1158/1538-7445.AM2016-1524

Published: 15 July 2016

View article

Journal Articles

Abstract 91: The mutational landscape of mucinous carcinomas of the breast

Salvatore Piscuoglio, Charlotte KY Ng, Felipe C. Geyer, Carey A. Eberle, Elena Guerini-Rocco, Caterina Marchio, Anne Vincent-Salomon, Jorge S. Reis-Filho, Britta Weigelt

Cancer Res (2016) 76 (14_Supplement): 91.

DOI: https://doi.org/10.1158/1538-7445.AM2016-91

Published: 15 July 2016

View article

Journal Articles

Abstract A2-02: SF3B1 mutations constitute a novel therapeutic target in breast cancer

Sarah Maguire, Andri Leonidou, Patty Wai, Caterina Marchio, Charlotte Ng, Ana Sapino, Anne Vincent-Salomon, Jorge Reis-Filho, Britta Weigelt, Rachael Natrajan

Cancer Res (2015) 75 (22_Supplement_1): A2-02.

DOI: https://doi.org/10.1158/1538-7445.TRANSCAGEN-A2-02

Published: 15 November 2015

View article

Journal Articles

Abstract 3889: Genetic heterogeneity and distinct driver mutations in synchronous primary and metastatic breast cancers from therapy-naïve patients

Charlotte K. Y. Ng, Francois-Clement Bidard, Salvatore Piscuoglio, Raymond S. Lim, Jean-Yves Pierga, Paul Cottu, Anne Vincent-Salomon, Agnes Viale, Larry Norton, Brigitte Sigal, Britta Weigelt, Jorge S. Reis-Filho

Cancer Res (2015) 75 (15_Supplement): 3889.

DOI: https://doi.org/10.1158/1538-7445.AM2015-3889

Published: 01 August 2015

View article

Journal Articles

Abstract 3885: Mutational landscape and copy number alterations of mucinous breast carcinoma

Salvatore Piscuoglio, Charlotte Ng, Carey A. Eberle, Elena Guerini-Rocco, Caterina Marchio, Odette Mariani, Anne Vincent-Salomon, Britta Weigelt, Jorge S. Reis-Filho

Cancer Res (2015) 75 (15_Supplement): 3885.

DOI: https://doi.org/10.1158/1538-7445.AM2015-3885

Published: 01 August 2015

View article

Journal Articles

Breast Cancer Cell–Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes

Cristina Ghirelli, Fabien Reyal, Marine Jeanmougin, Raphaël Zollinger, Philémon Sirven, Paula Michea, Christophe Caux, Nathalie Bendriss-Vermare, Marie-Hélène Donnadieu, Martial Caly, Virginie Fourchotte, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, Xavier Sastre-Garau, Vassili Soumelis

Cancer Res (2015) 75 (14): 2775–2787.

DOI: https://doi.org/10.1158/0008-5472.CAN-14-2386

Published: 14 July 2015

View article

Includes: Supplementary data

Journal Articles

Abstract P6-03-05: Dual HER2 blockade of an activating driver HER3 mutation: A proof of principle study in a metastatic breast cancer patient

Francois-Clement Bidard, Ck Ng, Ezgi Tulukcuoglu, S Piscuoglio, Stephanie Descroix, Laurent Mignot, Jean-Louis Viovy, Paul Cottu, Brigitte Sigal, Anne Vincent-Salomon, Britta Weigelt, Jean-Yves Pierga, Jorge Reis-Filho

Cancer Res (2015) 75 (9_Supplement): P6-03-05.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P6-03-05

Published: 01 May 2015

View article

Journal Articles

Abstract P1-07-02: Mesenchymal stem cell regulated microRNAs converge on the speech gene FOXP2 and regulate breast cancer metastasis

Benjamin G Cuiffo, Antoine Campagne, George W Bell, Antonio Lembo, Francesca Orso, Evan Lien, Manoj K Bhasin, Monica Raimo, Summer E Hanson, Andriy Marusyk, Peiman Hematti, Kornelia Polyak, Odette Mariani, Stefano Volinia, Anne Vincent-Salomon, Daniela Taverna, Antoine E Karnoub

Cancer Res (2015) 75 (9_Supplement): P1-07-02.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P1-07-02

Published: 01 May 2015

View article

2 3

NARROW

Abstract 1724: Pancancer evaluation of tumor infiltrating lymphocytes (TILs) and PD-L1 in SHIVA-01 trial patients with different biopsy sites and histological types

Abstract PD11-04: A multi-feature AI-based solution for cancer diagnosis in breast biopsies: A prospective blinded multi-site clinical study

Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC)

Abstract P1-07-01: Real time detection of ESR1 mutation in blood by droplet digital PCR in the PADA-1 trial: Feasibility and cross-validation with NGS

Abstract PS12-03: Letrozole and palbociclib versus 3^rd generation chemotherapy as neoadjuvant treatment in luminal breast cancer: Survival results of the UNICANCER-NeoPAL study

Abstract P2-14-10: Prosigna® test in clinical routine: Impact on adjuvant chemotherapy decision and medico-economic considerations in France

Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP

Abstract P2-08-21: Outcomes results of Prosigna® test in early breast cancer patients: Experience of Institut Curie, France

Abstract P5-02-04: Upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast to reduce inter-observer variability: The DCISion study

Abstract 3867: Activating ESR1 mutations detection by single ddPCR assay

Abstract 774: Anti-Müllerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy

Abstract 2973: A comprehensive panel of patient-derived xenografts representing the molecular heterogeneity and diversity of triple-negative breast cancer

Abstract 1524: Mutations and gene copy number variations landscape of metastases of various cancer types from patients enrolled in the SHIVA trial

Abstract 91: The mutational landscape of mucinous carcinomas of the breast

Abstract A2-02: SF3B1 mutations constitute a novel therapeutic target in breast cancer

Abstract 3889: Genetic heterogeneity and distinct driver mutations in synchronous primary and metastatic breast cancers from therapy-naïve patients

Abstract 3885: Mutational landscape and copy number alterations of mucinous breast carcinoma

Breast Cancer Cell–Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes

Abstract P6-03-05: Dual HER2 blockade of an activating driver HER3 mutation: A proof of principle study in a metastatic breast cancer patient

Abstract P1-07-02: Mesenchymal stem cell regulated microRNAs converge on the speech gene FOXP2 and regulate breast cancer metastasis

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only